CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Opimus Group Nyrt Company Snapshot
Opimus Group Nyrt operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Opimus Group Nyrt with three other pharmaceutical manufacturers in Europe: Allergy Therapeutics PLC of the United Kingdom (2016 sales of £48.51 million [US$61.25 million] of which 100% was Pharmaceuticals), Eco Animal Health Group Plc of the United Kingdom (£47.14 million [US$59.52 million] of which 100% was Animal Health Product), and Malin Corporation Plc which is based in Ireland (42.10 million Euro [US$46.88 million] ).

Sales Analysis. Opimus Group Nyrt reported sales of 15.31 billion Hungarian Forints (US$55.13 million) for the year ending December of 2016. This represents an increase of 34.6% versus 2015, when the company's sales were 11.38 billion Hungarian Forints. Despite this increase, sales are still below the level achieved in 2014, when Opimus Group Nyrt reported sales of 17.51 billion Hungarian Forints.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Opimus Group Nyrt
  Stock Performance Chart for Opimus Group Nyrt
 
  Stock Data: Recent Stock Performance:
  Current Price (6/16/2017): 107.00
(Figures in Hungarian Forints)
1 Week -10.8%   13 Weeks 127.7%  
4 Weeks 132.6%   52 Weeks 723.1%  
 
Opimus Group Nyrt Key Data:
  Ticker: OPIMUS Country: Hungary
  Exchanges: BUD Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 15,314,717,000
(Year Ending Jan 2017).
Employees: 1,070
  Currency: Hungarian Forints Market Cap: 33,224,144,996
  Fiscal Yr Ends: December Shares Outstanding: 310,506,028
  Share Type: Namenaktie Closely Held Shares: 150,090,632
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.